PROVIDER PROFILE · NPI 1821235474
Nikolaos MyriounisMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
51
Unique beneficiaries
—
Total services
88
Distinct HCPCS
3
Medicare payment
$4K
Peer benchmark
Total Medicare services vs. 247 Hematology-Oncology providers in WA — top quintile (cohort median 770).
PRESCRIBING · PART D · 2024
Total Rx claims
245
Beneficiaries
—
Total drug cost
$244K
Distinct drugs
11
Brand share
0.0%
Top prescribed drugs
Dexamethasone47 claims
Oxycodone Hcl26 claims
Ondansetron Hcl25 claims
Prochlorperazine Maleate24 claims
Prednisone24 claims
QUALITY · MIPS · 2024
Final MIPS score
71.2
Quality
69.2
Cost
51.4
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
-0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$154
Payment records
1
By payment type
Food and Beverage$154
Top paying entities
Food and Beverage$154
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Nikolaos Myriounis's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| NPI 1346390879 | 20 | 78 |
| Christopher Murdock Diagnostic Radiology · Chesterfield, MO | 12 | 42 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE